SCHEMBL6711067

SCHEMBL6711067

CN(C)CCCC[CH]Cc1cccc2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 3/20 0.50
CYP1A2 P05177 3/20 0.47
CYP2C19 P33261 3/20 0.47
CYP2D6 P10635 2/20 0.47
LMNA P02545 3/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPK1 P28482 2/20 0.41
MAPT P10636 1/20 0.41
RAD52 P43351 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NR1I2 O75469 1/20 0.40
DRD2 P14416 1/20 0.40
ADRA2C P18825 1/20 0.40
CNR1 P21554 1/20 0.40
SLC6A2 P23975 1/20 0.40
HTR2A P28223 1/20 0.40
SLC6A4 P31645 1/20 0.40
ADRA1A P35348 1/20 0.40
OPRK1 P41145 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10391191 0.95 HTR1B (0.49) HTR1BCYP1A2CYP2C19CYP2D6LMNA
SCHEMBL18243028 0.81 CYP2C19 (0.44) CYP1A2CYP2C19CYP2D6HTTCYP2C9
SCHEMBL10390339 0.79 CYP2C19 (0.55) HTR1BCYP1A2CYP2C19CYP2D6LMNA
SCHEMBL18242791 0.77 CYP2C19 (0.47) CYP1A2CYP2C19CYP2D6LMNANR1I2
SCHEMBL4006370 0.77 CYP1A2 (0.56) HTR1BCYP1A2CYP2C19CYP2D6LMNA
Hydrochloric Acid SCHEMBL25415894 0.76 HTR1B (0.54) HTR1BCYP1A2CYP2C19CYP2D6LMNA
Hydrochloric Acid SCHEMBL25414990 0.76 HTR1B (0.54) HTR1BCYP1A2CYP2C19CYP2D6LMNA
Hydrochloric Acid SCHEMBL25416546 0.76 HTR1B (0.54) HTR1BCYP1A2CYP2C19CYP2D6LMNA
Water SCHEMBL11573030 0.76 HTR1B (0.54) HTR1BCYP1A2CYP2C19CYP2D6LMNA
Water SCHEMBL11571498 0.76 HTR1B (0.54) HTR1BCYP1A2CYP2C19CYP2D6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392315-A1 METHODS OF TREATING ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-03 EP disclosed
WO-2002100410-A1 METHODS OF TREATING ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed